Dabur India Ltd.
FMCG · NSE
52-week range
₹403 – ₹574
From 52w high
-15.0%
RSI (14)
68.4
vs SMA 50 / 200
↑ 50 · ↓ 200
Dabur India (₹487.70) is a mid-cap FMCG company ranked 2nd of 6 peers on PE (45.6x, trailing) but 4th of 6 on ROE (16.24%) and quality score (47). The stock has returned 3.04% over 12 months, is trading 2.0% below its 200-DMA, and reported a 34.6% decline in Q4 FY26 net profit driven by Middle East business headwinds.
- ✓5-year earnings CAGR of 15.2% exceeds 5-year revenue CAGR of 7.3%, indicating margin expansion at the earnings line over the medium term.
- ✓FCF was positive in 4 of the last available years and ROE exceeded 15% in 4 of those years — showing reasonable, if not exceptional, capital efficiency consistency.
- ✓Forward PE of 36.9x is materially lower than trailing PE of 45.6x, indicating that consensus earnings estimates imply significant profit growth in the upcoming year.
- ✓Dividend yield of 1.69% provides an income component; the company declared its highest-ever dividend alongside Q4 FY26 results.
- ✗Q4 FY26 net profit fell 34.6% YoY on Middle East revenue headwinds, representing a sharp single-quarter earnings deterioration that reflects geographic concentration in the international segment.
- ✗Debt-to-equity of 10.907 is substantially above typical FMCG norms; while FMCG businesses can carry operational leverage, this level sits well above peers in the same sector comparison group.
- ✗ROE of 16.24% and quality score of 47 both rank 4th of 6 in the FMCG peer set, placing DABUR in the lower half of the peer group on capital efficiency and composite quality.
- ✗Stock has delivered only 3.04% price appreciation over 12 months and trades below the 200-DMA (₹497.47), reflecting sustained underperformance relative to its own longer-term trend line.
- ·Q4 FY26 results released around May 7, 2026, produced conflicting headlines — one source reported a 34.6% profit decline citing Mideast headwinds, another reported a 15% profit rise alongside a record dividend declaration; the divergence likely reflects differing comparison periods (quarterly consolidated vs domestic-only or vs prior-year quarter) and warrants verification of the exact base used.
- ·Business Standard (Apr 15, 2026) highlighted rural demand softness and rising input costs as structural challenges clouding the near-term growth outlook for DABUR.
- ·Dabur published notices for a Sesa Care merger meeting (May 2, 2026), indicating an active corporate restructuring process that could affect the consolidated financials and segment reporting going forward.
- ?Does the Q4 FY26 earnings decline reflect a temporary Middle East market disruption, or does it indicate a structural deterioration in the international business that has historically contributed a meaningful share of consolidated revenue?
- ?How has Dabur’s debt-to-equity of 10.907 evolved over the past 5 years, and what specific liabilities or financing structures drive the elevated figure relative to peers such as HINDUNILVR and NESTLEIND?
- ?With forward PE compressing from 45.6x to 36.9x, what earnings growth rate is embedded in that forward estimate, and how does that growth assumption compare to the 5-year historical earnings CAGR of 15.2%?
- ?If the Sesa Care merger is completed, how would the combined entity’s revenue mix, geographic exposure, and debt profile differ from the current standalone DABUR structure?
PE
45.6
Forward PE
36.9
ROE
+16.2%
Profit margin
+14.4%
D/E
10.91
Dividend yield
+1.7%
Quality score
47/100
ROE 5y above 15%
4/5 yrs
FCF 5y positive
4/5 yrs
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.Analysis generated 11 May 2026.